Protara Therapeutics, Inc. Annual Depreciation in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Protara Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
  • Protara Therapeutics, Inc. Depreciation for the quarter ending March 31, 2024 was $83K, a 7.79% increase year-over-year.
  • Protara Therapeutics, Inc. annual Depreciation for 2023 was $341K, a 37.5% increase from 2022.
  • Protara Therapeutics, Inc. annual Depreciation for 2022 was $248K, a 112% increase from 2021.
  • Protara Therapeutics, Inc. annual Depreciation for 2021 was $117K, a 13.6% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $341K +$93K +37.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-13
2022 $248K +$131K +112% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-13
2021 $117K +$14K +13.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-08
2020 $103K +$87K +544% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-09
2019 $16K -$99K -86.1% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 $115K -$33K -22.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $148K +$25K +20.3% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-13
2016 $123K +$66K +116% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-13
2015 $57K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.